2026 Vicente E. Torres: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	121	3621	3387	1997	1845	445	51872

Vicente E. Torres publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Vicente E. Torres sits on this spectrum.

101 publications 1,796+

This scientist: 445 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Vicente E. Torres D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Vicente E. Torres sits on this spectrum.

70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Vicente E. Torres is affiliated with the Mayo Clinic in the United States and has contributed extensively to research in the fields of biochemistry, genetics, molecular biology, and medicine. Their work spans several subfields, including genetics, molecular biology, pathology and forensic medicine, nephrology, and pediatric, perinatal, and child health.

Torres's research topics predominantly focus on genetic and kidney cyst diseases, renal and related cancers, biomedical research and pathophysiology, genetic syndromes and imprinting, pediatric urology and nephrology studies, renal diseases and glomerulopathies, and fetal and pediatric neurological disorders.

Some of their recent significant papers include:

Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease, 2020, published in Cells
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype, 2021, published in The American Journal of Human Genetics
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure, 2023, published in Nature Medicine
Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy, 2021, published in American Journal of Kidney Diseases
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD, 2020, published in JCI Insight

Frequent co-authors of Vicente E. Torres include:

Peter C. Harris
Fouad T. Chebib
Arlene B. Chapman
Ronald D. Perrone
Timothy L. Kline

The scientist's work is often published in prominent venues such as:

Journal of the American Society of Nephrology
Kidney International Reports
Kidney International
American Journal of Kidney Diseases
Kidney360

Best Publications

Autosomal dominant polycystic kidney disease

Vicente E Torres;Peter C Harris;Yves Pirson

1999
Citations
Tolvaptan in patients with autosomal dominant polycystic kidney disease

Vicente E. Torres;Arlene B. Chapman;Olivier Devuyst;Olivier Devuyst;Ron T. Gansevoort

1640
Citations
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

Lesley A Inker;Nwamaka D Eneanya;Josef Coresh;Hocine Tighiouart

1106
Citations
Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

Wko Lau;ML Blute;AL Weaver;VE Torres

1019
Citations
Volume Progression in Polycystic Kidney Disease

Jared J. Grantham;Vicente E. Torres;Arlene B. Chapman;Lisa M. Guay-Woodford

903
Citations
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Vincent H Gattone;Xiaofang Wang;Peter C Harris;Vicente E Torres

874
Citations
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Christopher J. Ward;Marie C. Hogan;Sandro Rossetti;Denise Walker

839
Citations
Autosomal dominant polycystic kidney disease: the last 3 years

Vicente E. Torres;Peter C. Harris

788
Citations
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.

Vicente E Torres;Xiaofang Wang;Qi Qian;Stefan Somlo

645
Citations
Polycystic kidney disease.

Carsten Bergmann;Lisa M. Guay-Woodford;Peter C. Harris;Shigeo Horie

623
Citations
Defective planar cell polarity in polycystic kidney disease

Evelyne Fischer;Emilie Legue;Antonia Doyen;Faridabano Nato

591
Citations
Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials

María V. Irazabal;Laureano J. Rangel;Eric J. Bergstralh;Sara L. Osborn

574
Citations
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Vicente E Torres;Arlene B Chapman;Olivier Devuyst;Olivier Devuyst;Ron T Gansevoort

569
Citations
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Arlene B. Chapman;Olivier Devuyst;Kai-Uwe Eckardt;Ron T. Gansevoort

542
Citations
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

Carmen Garcia Iglesias;Vicente E. Torres;Kenneth P. Offord;Keith E. Holley

513
Citations
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

Robert W. Schrier;Robert W. Schrier;Kaleab Z. Abebe;Ronald D. Perrone;Vicente E. Torres

499
Citations
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

Sandro Rossetti;Mark B. Consugar;Arlene B. Chapman;Vicente E. Torres

479
Citations
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Arlene B. Chapman;Lisa M. Guay-Woodford;Jared J. Grantham;Vicente E. Torres

471
Citations
Identification and Characterization of Polycystin-2, the PKD2 Gene Product

Yiqiang Cai;Yoshiko Maeda;Anna Cedzich;Vicente E. Torres

456
Citations
Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat

Xiaofang Wang;Vincent Gattone;Peter C. Harris;Vicente E. Torres

443
Citations

Frequent Co-Authors

Peter C. Harris Mayo Clinic

Arlene B. Chapman University of Chicago

Kyongtae T. Bae University of Pittsburgh

Jared J. Grantham University of Kansas

Ron T. Gansevoort University Medical Center Groningen

Olivier Devuyst University of Zurich

Stefan Somlo Yale University

Robert W. Schrier University of Colorado Denver

Nicholas F. LaRusso Mayo Clinic

Bradley J. Erickson Mayo Clinic

External Links

Personal website of Vicente E. Torres

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For students considering careers in medicine or healthcare, alternative degrees and online study options can provide flexibility and cost savings. There are several in-demand programs that can complement or expand your medical career without the traditional route of attending a U.S. medical school.

Pursuing a Master’s in Healthcare Administration is a popular option for those seeking leadership roles in hospitals or clinics—explore the cheapest mha online programs to find affordable pathways into healthcare management.

If you are already a nurse, consider advancing your career by looking into the cheapest bsn to dnp programs, which offer a direct and flexible track to a Doctor of Nursing Practice degree online.

Those interested in pharmacy can benefit from pharm d online programs, providing accessibility to advanced pharmaceutical training and degrees.

Finally, the rapidly growing field of health information management offers online training as well. You can prepare for the RHIA credential through rhia certification programs online, opening career doors in health data and electronic records.